Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.
Berndt A, Hofmann-Winkler H, Tavalai N, Hahn G, Stamminger T. Berndt A, et al. Among authors: tavalai n. J Virol. 2009 Dec;83(24):12881-94. doi: 10.1128/JVI.01525-09. Epub 2009 Oct 7. J Virol. 2009. PMID: 19812159 Free PMC article.
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.
Tavalai N, Stamminger T. Tavalai N, et al. Viruses. 2009 Dec;1(3):1240-64. doi: 10.3390/v1031240. Epub 2009 Dec 15. Viruses. 2009. PMID: 21994592 Free PMC article.
New insights into the role of the subnuclear structure ND10 for viral infection.
Tavalai N, Stamminger T. Tavalai N, et al. Biochim Biophys Acta. 2008 Nov;1783(11):2207-21. doi: 10.1016/j.bbamcr.2008.08.004. Epub 2008 Aug 16. Biochim Biophys Acta. 2008. PMID: 18775455 Free article. Review.
Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.
Kaspari M, Tavalai N, Stamminger T, Zimmermann A, Schilf R, Bogner E. Kaspari M, et al. Among authors: tavalai n. FEBS Lett. 2008 Mar 5;582(5):666-72. doi: 10.1016/j.febslet.2008.01.040. Epub 2008 Jan 31. FEBS Lett. 2008. PMID: 18242185 Free article.
Insertion of an EYFP-pp71 (UL82) coding sequence into the human cytomegalovirus genome results in a recombinant virus with enhanced viral growth.
Tavalai N, Kraiger M, Kaiser N, Stamminger T. Tavalai N, et al. J Virol. 2008 Nov;82(21):10543-55. doi: 10.1128/JVI.01006-08. Epub 2008 Aug 20. J Virol. 2008. PMID: 18715911 Free PMC article.
General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.
Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L. Zydek M, et al. Among authors: tavalai n. J Gen Virol. 2011 Dec;92(Pt 12):2757-2769. doi: 10.1099/vir.0.034173-0. Epub 2011 Aug 10. J Gen Virol. 2011. PMID: 21832009
Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle.
Tavalai N, Adler M, Scherer M, Riedl Y, Stamminger T. Tavalai N, et al. J Virol. 2011 Sep;85(18):9447-58. doi: 10.1128/JVI.00870-11. Epub 2011 Jul 6. J Virol. 2011. PMID: 21734036 Free PMC article.
Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100.
Adler M, Tavalai N, Müller R, Stamminger T. Adler M, et al. Among authors: tavalai n. J Gen Virol. 2011 Jul;92(Pt 7):1532-1538. doi: 10.1099/vir.0.030981-0. Epub 2011 Apr 6. J Gen Virol. 2011. PMID: 21471311
Intrinsic cellular defense mechanisms targeting human cytomegalovirus.
Tavalai N, Stamminger T. Tavalai N, et al. Virus Res. 2011 May;157(2):128-33. doi: 10.1016/j.virusres.2010.10.002. Epub 2010 Oct 8. Virus Res. 2011. PMID: 20934469 Review.
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection.
Tavalai N, Papior P, Rechter S, Stamminger T. Tavalai N, et al. J Virol. 2008 Jan;82(1):126-37. doi: 10.1128/JVI.01685-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942542 Free PMC article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page